MedPath

Agreement of the probe which measures surface changes using electrical property with colposcopy to identify pre cancer lesions in cervix

Not Applicable
Conditions
Health Condition 1: R876- Abnormal cytological findings in specimens from female genital organsHealth Condition 2: R878- Other abnormal findings in specimens from female genital organsHealth Condition 3: R399- Unspecified symptoms and signs involving the genitourinary system
Registration Number
CTRI/2023/09/057932
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Abnormal Pap cytology or

abnormal VIA/VILI positive or

HPV DNA positive

Exclusion Criteria

1.Post total hysterectomy patients

2.Menstruating at the time of visit

3.Pregnant at the time of visit

4.Active cervicitis or vulvovaginitis

5.Obvious growth in cervix suggestive of cancer

6.Unable to do low lithotomy position due to disease, disability or mental instability

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concordance between Eletrical Impedance Spectroscopy with Colposcopic Swede Score to detect high grade lesionsTimepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
Proportion of high grade lesions detected by Electrical Impedance Spectroscopy and standard colposcopy to accurately diagnose preinvasive lesions CIN2/3Timepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath